Friday, 26 May 2017

Detailed Study of the Enteral Stents Market in Europe

MediPoint: Enteral Stents - Europe Forecast and Market Analysis is a new market research publication announced by Reportstack. Enteral stents are a palliative treatment option for constrictions caused primarily by various cancers. The primary cancers which cause constrictions requiring the use of enteral stents are esophageal cancer, gastric cancer, pancreatic cancer, and colorectal cancer. 
There are three primary enteral stents; the covered enteral stent, the partially covered enteral stents, and the non-covered enteral stent. The market is led by three key players. The market will continue to grow as cancer prevalence increases and patients become more familiar with enteral stenting as a treatment option. 
This report examines the enteral stents market in 21 major European markets: Austria, Belgium, Czech Republic, Denmark, Finland, France, Greece, Germany, Hungary, Ireland, Italy, Netherlands, Norway, Poland, Portugal, Russia, Spain, Sweden, Switzerland, Turkey and the UK.
This report provides insight into the adoption trends, market dynamics, competitive landscape, marketed products, current players, as well as market outlooks in the European market.
Companies Mentioned
Boston Scientific Cook Medical Taewoong Medical
Debora White
Manager - Marketing
Ph: +1-888-789-6604
ReportstackMarket Research

No comments:

Post a Comment